바이오 분석 서비스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global bioanalytical services market size is expected to reach USD 10.99 Billion in 2034 from USD 4.05 Billion in 2025, growing at a CAGR of 11.73% during 2026-2034.The Global Bioanalytical Services Market has experienced substantial growth due to the rising demand for drug development and clinical research across pharmaceutical and biotechnology industries. Increasing prevalence of chronic diseases and the expansion of biologics and biosimilars have significantly boosted the need for accurate bioanalytical testing. Regulatory requirements for drug safety and efficacy have further strengthened the demand for specialized analytical services. Technological advancements in mass spectrometry and chromatography techniques have improved sensitivity and efficiency, enabling service providers to handle complex biological samples and support large-scale clinical trials worldwide.

Key growth drivers include the surge in outsourcing activities by pharmaceutical companies aiming to reduce operational costs and accelerate time-to-market. Small and mid-sized biotech firms particularly rely on contract research organizations for bioanalytical testing expertise. The increasing adoption of personalized medicine and biomarker-based studies has also intensified demand for advanced analytical platforms. Moreover, government funding for life sciences research and expanding clinical trial pipelines in emerging economies contribute significantly to market expansion, fostering strategic collaborations between research institutions and service providers.

Looking ahead, the market is expected to benefit from innovations in automation, artificial intelligence-driven data analysis, and high-throughput screening technologies. The integration of digital platforms for data management and regulatory compliance will further streamline workflows. Growth opportunities are likely to emerge from cell and gene therapy development, where precise bioanalytical validation is essential. As pharmaceutical pipelines diversify and regulatory scrutiny increases globally, the demand for reliable, scalable, and technologically advanced bioanalytical services will continue to strengthen in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Service

• Immunochemistry Services
• Quantitative Immunoassays
• Cell-based Neutralization Assays
• LCMS Method Development
• Discovery Phase Bioanalysis
• LCMS Sample Bioanalysis
• GCP Bioanalysis Service
• Biomarker Assays
• Protein Analysis
• Others

By Type

• Small Molecule Bioanalysis
• Large Molecule Bioanalysis
• Others

By End-user

• Pharma & Biotechnology Companies
• Contract Research Organizations
• Others

COMPANIES PROFILED

• Labcorp, Thermo Fisher Scientific Inc. (PPD), Charles River Laboratories International Inc., Eurofins Scientific, ICON plc, IQVIA Inc., SGS SA, Syneos Health, WuXi AppTec, Intertek Group plc, Medpace Holdings, Inc., Pace Analytical Services LLC, Frontage Laboratories Inc., BioAgilytix Labs, Altasciences, Almac Group, Celerion, Pharmaron, LGC Limited, KCAS Bioanalytical and Biomarker Services

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOANALYTICAL SERVICES MARKET: BY SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service
• 4.2. Immunochemistry Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Quantitative Immunoassays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cell-based Neutralization Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. LCMS Method Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Discovery Phase Bioanalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. LCMS Sample Bioanalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. GCP Bioanalysis Service Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Biomarker Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Protein Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOANALYTICAL SERVICES MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Small Molecule Bioanalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Large Molecule Bioanalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOANALYTICAL SERVICES MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Pharma & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOANALYTICAL SERVICES MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Service
  • 7.2.2 By Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Service
  • 7.3.2 By Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Service
  • 7.4.2 By Type
  • 7.4.3 By End-user
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Service
  • 7.5.2 By Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Service
  • 7.6.2 By Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOANALYTICAL SERVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Labcorp
  • 9.2.2 Thermo Fisher Scientific Inc. (PPD)
  • 9.2.3 Charles River Laboratories International Inc
  • 9.2.4 Eurofins Scientific
  • 9.2.5 ICON Plc
  • 9.2.6 IQVIA Inc
  • 9.2.7 SGS SA
  • 9.2.8 Syneos Health
  • 9.2.9 WuXi AppTec
  • 9.2.10 Intertek Group Plc
  • 9.2.11 Medpace HoldingsInc
  • 9.2.12 Pace Analytical Services LLC
  • 9.2.13 Frontage Laboratories Inc
  • 9.2.14 BioAgilytix Labs
  • 9.2.15 Altasciences
  • 9.2.16 Almac Group
  • 9.2.17 Celerion
  • 9.2.18 Pharmaron
  • 9.2.19 LGC Limited
  • 9.2.20 KCAS Bioanalytical And Biomarker Services